← back to search

Min Qian

Columbia University · US
Area of research
Cardiology and Cardiovascular Medicine · Statistics and Probability
Research interest
Research focused on Heart failure and Cardiology, with related work in GDF15, Patient portal, Cetuximab. Notable publications include 'Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway', 'Growth Differentiation Factor 15 (GDF-15) in Patients Admitted for Acute Heart Failure: Results from the RELAX-AHF Study', and 'A Multimarker Multi-Time Point-Based Risk Stratification Strategy in Acute Heart Failure: Results from the RELAX-AHF Trial'.
h-index
citations
556
works
9
NIH funding
primary concept
email

Recent publications

Valacyclovir Treatment of Early Symptomatic Alzheimer Disease
JAMA 2025cited by 6position: middledoi
Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway
JNCI Journal of the National Cancer Institute 2020cited by 147position: middledoi
Cognitive Decline Over Time in Patients With Systolic Heart Failure
JACC Heart Failure 2019cited by 42position: middledoi
Engaging hospitalized patients with personalized health information: a randomized trial of an inpatient portal
Journal of the American Medical Informatics Association 2018cited by 55position: middledoi
Left Atrial Volume and Cardiovascular Outcomes in Systolic Heart Failure: Effect of Antithrombotic Treatment
ESC Heart Failure 2018cited by 32position: middledoi
A Multimarker Multi-Time Point-Based Risk Stratification Strategy in Acute Heart Failure: Results from the RELAX-AHF Trial
European Journal of Heart Failure 2017cited by 106position: middledoi
CHA2DS2-VASc Score and Adverse Outcomes in Patients with Heart Failure with Reduced Ejection Fraction and Sinus Rhythm
European Journal of Heart Failure 2016cited by 30position: middledoi
Growth Differentiation Factor 15 (GDF-15) in Patients Admitted for Acute Heart Failure: Results from the RELAX-AHF Study
European Journal of Heart Failure 2015cited by 109position: middledoi
Recurrent Stroke in the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
Cerebrovascular Diseases 2014cited by 29position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John R. Teerlink · University of Glasgow6 papers (2014–2019)Piotr Ponikowski · University of Business in Wrocław6 papers (2014–2019)Ralph L. Sacco · Lotus Clinical Research4 papers (2014–2019)Patrick M. Pullicino · New York University4 papers (2014–2019)Dirk J. Lok · New York University4 papers (2014–2019)Susan Graham · New York University4 papers (2014–2019)Conrado J. Estol · Stat Research4 papers (2014–2019)John L.P. Thompson · New York University4 papers (2014–2019)Marco R. Di Tullio · NewYork–Presbyterian Hospital4 papers (2014–2019)Gregory Y.H. Lip · Medical University of Białystok4 papers (2014–2019)J.P. Mohr · New York University4 papers (2014–2019)Douglas L. Mann · Washington University in St. Louis4 papers (2014–2019)Bruce Levin · New York University3 papers (2014–2018)Arthur J. Labovitz · New York University3 papers (2016–2019)Shunichi Homma · NewYork–Presbyterian Hospital3 papers (2014–2019)Stefan D. Anker · Deutsches Herzzentrum München3 papers (2014–2018)Ronald S. Freudenberger · New York University3 papers (2016–2019)Richard Buchsbaum · New York University3 papers (2016–2019)Thomas M. Severin · Novartis (Switzerland)2 papers (2015–2017)Margaret F. Prescott · The University of Texas Southwestern Medical Center2 papers (2015–2017)